Journal article
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
Abstract
BACKGROUND: Patients with stable coronary artery disease and diabetes with previous percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk of ischaemic events. These patients are generally treated with aspirin. In this trial, we aimed to investigate if these patients would benefit from treatment with aspirin plus ticagrelor.
METHODS: The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus …
Authors
Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W
Journal
The Lancet, Vol. 394, No. 10204, pp. 1169–1180
Publisher
Elsevier
Publication Date
9 2019
DOI
10.1016/s0140-6736(19)31887-2
ISSN
0140-6736
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAspirinCardiovascular DiseasesCoronary AngiographyCoronary Artery BypassCoronary Artery DiseaseCoronary StenosisDiabetes Mellitus, Type 2Double-Blind MethodDrug Therapy, CombinationFemaleHemorrhageHumansHypoglycemic AgentsMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsSecondary PreventionStrokeTicagrelor